Compare

Weis Markets/$WMK

1D1W1M3M6MYTD1Y5YMAX

About Weis Markets

Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The company operates in a single segment, which is the retail segment. It derives revenues from customers through the retail sale of products including grocery, pharmacy and fuel from company owned supermarkets. The company derives all its revenue from sales within Pennsylvania and surrounding states.
Ticker
$WMK
Primary listing
NYSE
Employees
22,000

Weis Markets Metrics

BasicAdvanced
$1.8B
18.49
$4.02
0.44
$1.36
1.83%

Bulls say / Bears say

Second-quarter revenue rose 4.6%, while comparable sales grew 2.3% year on year and 4.1% on a two-year stacked basis. Weis says customers are responding to its value promotions and loyalty offers, including at newer stores. (Weis Markets)
First-half profitability improved: gross margin increased to 26.1% from 25.1%, operating income rose 24.6% and net income gained 13.1%. Earnings per share increased 21.3% to $2.05. (SEC)
Weis opened a new 65,000-square-foot Millsboro store in June, adding capacity in southern Delaware with fresh-food departments and online ordering. Further expansion and store upgrades could support growth and help the chain stand out locally. (Weis Markets)
Quarterly costs outpaced sales: operating expenses rose 8.3% against 4.6% revenue growth, and operating income fell 3.7%. Net income declined 9.6%, showing how quickly cost pressure can weigh on the supermarket’s slim profits. (SEC)
Fuel-free comparable sales fell 0.4% in the second quarter, compared with a 2.3% rise including fuel. This points to weak underlying sales momentum in Weis’s core stores, despite the headline growth in total comparable sales. (SEC)
New Medicare drug-price rules reduced pharmacy revenue growth by about $18.19 million in the first half. This regulatory headwind may constrain a business that accounted for 13.2% of first-half net sales. (Weis Markets, SEC)
Data summarised monthly by Lightyear AI. Last updated on 25 Oct 2026.

Weis Markets Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Funds containing Weis Markets

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.